title: Advances in the management of leg ulcers--the potential role of growth factors.
abstract: Venous ulcers are a major health problem because of the increased costs of the treatment and the refractory nature of the ulcers. The treatment cost is estimated to be around 1 billion dollars per year in the United States (US), and the average cost for one patient over a lifetime exceeds dollars 400,000. There has been an increasing trend in the use of growth factors in their management. Genetic engineering has revolutionised the research of wound healing, as the majority of recombinant growth factors are now available for in vitro and in vivo studies. Online searches of Medline, Pub Medical and Embase were carried out using the terms venous ulcers, leg ulcers, growth factors and growth hormone. The literature regarding the potential role of growth factors in the management of leg ulcers is reviewed. The important clinical studies are critically analysed with a view to appreciate the emerging therapies and the further research possibilities in the management of venous leg ulcers. Clinical results with the use of growth factors in non-healing wounds are encouraging. However, small sample sizes and inconsistent end points in different clinical studies have been the main hurdle in reaching a definite conclusion. Further research is needed to provide the definite evidence. Future developments may include different delivery methods for the growth factors, use of different combinations of growth factors administered simultaneously or, sequentially, bioengineered skin grafts and chemical induction of angiogenesis with the use of gene transfer techniques.
authors.affiliation: Salisbury District Hospital Salisbury, UK. mkhan702@aol.com
authors.forename: Muhammad N
authors.initials: MN
authors.lastname: Khan
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Davies
mesh_terms: D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000628:therapy*; D009779:Occlusive Dressings
chemical_list: D006133:Growth Substances